< Back to search
Filter
1

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04883437

Phase2, Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

for
Follicular Lymphoma, Mantle Cell Lymphoma, Hairy Cell Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT06340737

Phase1, Recruiting

Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

for
Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT04587687

Phase2, Recruiting

Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Richter Syndrome,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05388006

Phase2, Recruiting

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

for
Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06350318

Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for
Hematologic Malignancy, AML, ALL, BPDCN, MDS,
Location: New York NY, Washington DC, Ann Arbor MI, Cincinnati OH,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 1 - 21

Code: NCT05476770

Phase1, Recruiting

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

for
B-cell Lymphoma, Burkitt Lymphoma,
Location: Valhalla NY
Sponsor: New York Medical College

Sex: All

Age: 12 - 70

Code: NCT04491370

Phase1, Phase2, Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: New York NY, Richmond VA, Webster NY, Rochester NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05890352

Phase2, Recruiting

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

for
Metastatic Malignant Solid Neoplasm, Lymphoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05371132

Phase1, Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

for
Neurofibroma, Plexiform,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 35

Code: NCT02390752

Phase1, Recruiting

Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Los Angeles CA, Davis CA, San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT06252675

Phase2, Recruiting

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

for
Mantle Cell Lymphoma
Location: Charlottesville VA, Ann Arbor MI, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT03523975

Phase1, Phase2, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Norwich CT, Hackensack NJ, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

CAR T-cell Therapy in Patients With Renal Dysfunction

for
Non-hodgkin Lymphoma,B Cell, Multiple Myeloma,
Location: Atlanta GA
Sponsor: Northside Hospital, Inc.

Sex: All

Age: 18+

Code: NCT05909059

Phase2, Recruiting

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

for
Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01087333

Recruiting

Cord Blood Transplant in Adults With Blood Cancers

for
Acute Myelogenous Leukemia (AML),
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 65

Code: NCT05884333

Phase2, Recruiting

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

for
Hodgkin Lymphoma, Adult
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 18+

Code: NCT06421987

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0+

Code: NCT04195633

Phase2, Recruiting

First in Human, Dose Escalation Study of AN4005

for
Advanced Solid Tumor, Advanced Lymphoma
Location: The Bronx NY, Hackensack NJ, Fairfax VA, Greenville SC
Sponsor: Adlai Nortye Biopharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT04999384

Phase1, Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

for
Cutaneous T Cell Lymphoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT03932279

Recruiting